| Year |
Citation |
Score |
| 2023 |
Mu Q, Chai R, Pang B, Yang Y, Liu H, Zhao Z, Bao Z, Song D, Zhu Z, Yan M, Jiang B, Mo Z, Tang J, Sa JK, Cho HJ, ... ... Nam DH, et al. Identifying predictors of glioma evolution from longitudinal sequencing. Science Translational Medicine. 15: eadh4181. PMID 37792958 DOI: 10.1126/scitranslmed.adh4181 |
0.305 |
|
| 2022 |
Kim H, Sa JK, Kim J, Cho HJ, Oh HJ, Choi DH, Kang SH, Jeong DE, Nam DH, Lee H, Lee HW, Chung S. Recapitulated Crosstalk between Cerebral Metastatic Lung Cancer Cells and Brain Perivascular Tumor Microenvironment in a Microfluidic Co-Culture Chip. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2201785. PMID 35657027 DOI: 10.1002/advs.202201785 |
0.304 |
|
| 2020 |
Bastola S, Pavlyukov MS, Yamashita D, Ghosh S, Cho H, Kagaya N, Zhang Z, Minata M, Lee Y, Sadahiro H, Yamaguchi S, Komarova S, Yang E, Markert J, Nabors LB, ... ... Nam DH, et al. Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy. Nature Communications. 11: 4660. PMID 32938908 DOI: 10.1038/S41467-020-18189-Y |
0.409 |
|
| 2020 |
Lee WJ, Cho KR, Choi JW, Kong DS, Seol HJ, Nam DH, Lee JI. Gamma Knife Radiosurgery as a Primary Treatment for Nonfunctioning Pituitary Adenoma Invading the Cavernous Sinus. Stereotactic and Functional Neurosurgery. 1-7. PMID 32937617 DOI: 10.1159/000508737 |
0.383 |
|
| 2020 |
Sa JK, Chang N, Lee HW, Cho HJ, Ceccarelli M, Cerulo L, Yin J, Kim SS, Caruso FP, Lee M, Kim D, Oh YT, Lee Y, Her NG, Min B, ... ... Nam DH, et al. Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma. Genome Biology. 21: 216. PMID 32847614 DOI: 10.1186/S13059-020-02140-X |
0.362 |
|
| 2020 |
Koo H, Choi SW, Cho HJ, Lee IH, Kong DS, Seol HJ, Lee JI, Choi JW, Sa JK, Nam DH. Ethnic delineation of primary glioblastoma genome. Cancer Medicine. PMID 32794373 DOI: 10.1002/Cam4.3370 |
0.354 |
|
| 2020 |
Oldrini B, Vaquero-Siguero N, Mu Q, Kroon P, Zhang Y, Galán-Ganga M, Bao Z, Wang Z, Liu H, Sa JK, Zhao J, Kim H, Rodriguez-Perales S, Nam DH, Verhaak RGW, et al. MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas. Nature Communications. 11: 3883. PMID 32753598 DOI: 10.1038/S41467-020-17717-0 |
0.377 |
|
| 2020 |
Liu J, Cho YB, Hong HK, Wu S, Ebert PJ, Bray SM, Wong SS, Ting JC, Calley JN, Whittington CF, Bhagwat SV, Reinhard C, Wild R, Nam DH, Aggarwal A, et al. Molecular dissection of CRC primary tumors and their matched liver metastases reveals critical role of immune microenvironment, EMT and angiogenesis in cancer metastasis. Scientific Reports. 10: 10725. PMID 32612211 DOI: 10.1038/S41598-020-67842-5 |
0.394 |
|
| 2020 |
Choi SW, Cho HH, Koo H, Cho KR, Nenning KH, Langs G, Furtner J, Baumann B, Woehrer A, Cho HJ, Sa JK, Kong DS, Seol HJ, Lee JI, Nam DH, et al. Multi-Habitat Radiomics Unravels Distinct Phenotypic Subtypes of Glioblastoma with Clinical and Genomic Significance. Cancers. 12. PMID 32605068 DOI: 10.3390/Cancers12071707 |
0.321 |
|
| 2020 |
Lee HW, Chung W, Lee HO, Jeong DE, Jo A, Lim JE, Hong JH, Nam DH, Jeong BC, Park SH, Joo KM, Park WY. Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient. Genome Medicine. 12: 47. PMID 32460812 DOI: 10.1186/S13073-020-00741-6 |
0.407 |
|
| 2020 |
Kim M, Cho KR, Choi JW, Kong DS, Seol HJ, Nam DH, Lee JI. Two-staged gamma knife radiosurgery for treatment of numerous (>10) brain metastases. Clinical Neurology and Neurosurgery. 195: 105847. PMID 32371318 DOI: 10.1016/J.Clineuro.2020.105847 |
0.323 |
|
| 2020 |
Choi SW, Cho KR, Choi JW, Kong DS, Seol HJ, Nam DH, Lee JI. Pattern of disease progression following stereotactic radiosurgery in malignant glioma patients. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 32312626 DOI: 10.1016/J.Jocn.2020.04.047 |
0.341 |
|
| 2020 |
Lee HW, Cho HH, Joung JG, Jeon HG, Jeong BC, Jeon SS, Lee HM, Nam DH, Park WY, Kim CK, Seo SI, Park H. Integrative Radiogenomics Approach for Risk Assessment of Post-Operative Metastasis in Pathological T1 Renal Cell Carcinoma: A Pilot Retrospective Cohort Study. Cancers. 12. PMID 32252440 DOI: 10.3390/Cancers12040866 |
0.326 |
|
| 2020 |
Shin K, Shin H, Cho HJ, Kang H, Lee JK, Seo YJ, Shin YJ, Kim D, Koo H, Kong DS, Seol HJ, Lee JI, Lee HW, Nam DH. Sphere-Forming Culture for Expanding Genetically Distinct Patient-Derived Glioma Stem Cells by Cellular Growth Rate Screening. Cancers. 12. PMID 32120790 DOI: 10.3390/Cancers12030549 |
0.365 |
|
| 2020 |
Sa JK, Hong JY, Lee IK, Kim JS, Sim MH, Kim HJ, An JY, Sohn TS, Lee JH, Bae JM, Kim S, Kim KM, Kim ST, Park SH, Park JO, ... ... Nam DH, et al. Comprehensive pharmacogenomic characterization of gastric cancer. Genome Medicine. 12: 17. PMID 32070411 DOI: 10.1186/S13073-020-0717-8 |
0.336 |
|
| 2019 |
Han S, Shin H, Lee JK, Liu Z, Rabadan R, Lee J, Shin J, Lee C, Yang H, Kim D, Kim SH, Kim J, Oh JW, Kong DS, Lee JI, ... ... Nam DH, et al. Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target. Experimental & Molecular Medicine. 51: 147. PMID 31811117 DOI: 10.1038/S12276-019-0351-Y |
0.424 |
|
| 2019 |
Sa JK, Hwang JR, Cho YJ, Ryu JY, Choi JJ, Jeong SY, Kim J, Kim MS, Paik ES, Lee YY, Choi CH, Kim TJ, Kim BG, Bae DS, Lee Y, ... ... Nam DH, et al. Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers. Genome Biology. 20: 253. PMID 31771620 DOI: 10.1186/S13059-019-1848-3 |
0.319 |
|
| 2019 |
Lee HW, Son E, Lee K, Lee Y, Kim Y, Lee JC, Lim Y, Hur M, Kim D, Nam DH. Promising Therapeutic Efficacy of GC1118, an Anti-EGFR Antibody, against KRAS Mutation-Driven Colorectal Cancer Patient-Derived Xenografts. International Journal of Molecular Sciences. 20. PMID 31771279 DOI: 10.3390/Ijms20235894 |
0.31 |
|
| 2019 |
Han S, Shin H, Oh JW, Oh YJ, Her NG, Nam DH. The Protein Neddylation Inhibitor MLN4924 Suppresses Patient-Derived Glioblastoma Cells via Inhibition of ERK and AKT Signaling. Cancers. 11. PMID 31771104 DOI: 10.3390/Cancers11121849 |
0.389 |
|
| 2019 |
Kim KH, Cho YS, Seol HJ, Cho KR, Choi JW, Kong DS, Shin HJ, Nam DH, Lee JI. Comparison between retrosigmoid and translabyrinthine approaches for large vestibular schwannoma: focus on cerebellar injury and morbidities. Neurosurgical Review. PMID 31758338 DOI: 10.1007/S10143-019-01213-1 |
0.323 |
|
| 2019 |
Barthel FP, Johnson KC, Varn FS, Moskalik AD, Tanner G, Kocakavuk E, Anderson KJ, Abiola O, Aldape K, Alfaro KD, Alpar D, Amin SB, Ashley DM, Bandopadhayay P, Barnholtz-Sloan JS, ... ... Nam DH, et al. Longitudinal molecular trajectories of diffuse glioma in adults. Nature. PMID 31748746 DOI: 10.1038/S41586-019-1775-1 |
0.347 |
|
| 2019 |
Choi SW, Cho KR, Choi JW, Kong DS, Seol HJ, Nam DH, Lee JI. Fractionated stereotactic radiosurgery for malignant gliomas: comparison with single session stereotactic radiosurgery. Journal of Neuro-Oncology. PMID 31705245 DOI: 10.1007/S11060-019-03328-3 |
0.307 |
|
| 2019 |
Lee JJ, Kim HY, Dhong HJ, Chung SK, Kong DS, Nam DH, So YK, Hong SD. Delayed CSF Leakage after Treating Skull Base Tumors: Case Series of Nine Patients. World Neurosurgery. PMID 31442635 DOI: 10.1016/J.Wneu.2019.08.067 |
0.353 |
|
| 2019 |
Jeon C, Park KA, Hong SD, Choi JW, Seol HJ, Nam DH, Lee JI, Shin HJ, Kong DS. Clinical efficacy of optical coherence tomography to predict the visual outcome after endoscopic endonasal surgery for suprasellar tumors. World Neurosurgery. PMID 31421301 DOI: 10.1016/J.Wneu.2019.08.031 |
0.317 |
|
| 2019 |
Kim KH, Kong DS, Cho KR, Lee MH, Choi JW, Seol HJ, Kim ST, Nam DH, Lee JI. Outcome evaluation of patients treated with fractionated Gamma Knife radiosurgery for large (> 3 cm) brain metastases: a dose-escalation study. Journal of Neurosurgery. 1-10. PMID 31419791 DOI: 10.3171/2019.5.Jns19222 |
0.309 |
|
| 2019 |
Ju DG, Jeon C, Kim KH, Park KA, Hong SD, Seoul HJ, Shin HJ, Nam DH, Lee JI, Kong DS. Clinical significance of tumor-related edema of the optic tract affecting visual function in patients with sellar and suprasellar tumors. World Neurosurgery. PMID 31394363 DOI: 10.1016/J.Wneu.2019.07.218 |
0.339 |
|
| 2019 |
Lee M, Kim YS, Lee K, Kang M, Shin H, Oh JW, Koo H, Kim D, Kim Y, Kong DS, Nam DH, Lee HW. Novel Semi-Replicative Retroviral Vector Mediated Double Suicide Gene Transfer Enhances Antitumor Effects in Patient-Derived Glioblastoma Models. Cancers. 11. PMID 31370279 DOI: 10.3390/Cancers11081090 |
0.354 |
|
| 2019 |
Park HK, Yu DB, Sung M, Oh E, Kim M, Song JY, Lee MS, Jung K, Noh KW, An S, Song K, Nam DH, Kim YJ, Choi YL. Molecular changes in solitary fibrous tumor progression. Journal of Molecular Medicine (Berlin, Germany). PMID 31321477 DOI: 10.1007/S00109-019-01815-8 |
0.357 |
|
| 2019 |
Kim HY, Kim ST, Kim HJ, Jeon P, Byun HS, Kim YK, Cha J, Park GM, Nam DH, Kong DS. Differentiation of postoperative changes and residual tumors in dynamic contrast-enhanced sella MRI after transsphenoidal resection of pituitary adenoma. Medicine. 98: e16089. PMID 31277105 DOI: 10.1097/Md.0000000000016089 |
0.363 |
|
| 2019 |
Lee MH, Kim KH, Cho KR, Choi JW, Kong DS, Seol HJ, Nam DH, Lee JI. Volumetric changes of intracranial metastases during the course of fractionated stereotactic radiosurgery and significance of adaptive planning. Journal of Neurosurgery. 1-6. PMID 31151111 DOI: 10.3171/2019.3.Jns183130 |
0.335 |
|
| 2019 |
Shin H, Sa JK, Bae JS, Koo H, Jin S, Cho HJ, Choi SW, Kyoung JM, Kim JY, Seo YJ, Joung JG, Kim NKD, Son DS, Chung J, Lee T, ... ... Nam DH, et al. Clinical Targeted Next-Generation sequencing Panels for Detection of Somatic Variants in Gliomas. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 31096737 DOI: 10.4143/Crt.2019.036 |
0.361 |
|
| 2019 |
Lee M, Park C, Woo J, Kim J, Kho I, Nam DH, Park WY, Kim YS, Kong DS, Lee HW, Kim TJ. Preferential Infiltration of Unique Vγ9Jγ2-Vδ2 T Cells Into Glioblastoma Multiforme. Frontiers in Immunology. 10: 555. PMID 30967876 DOI: 10.3389/Fimmu.2019.00555 |
0.355 |
|
| 2019 |
Yun JW, Bae YK, Cho SY, Koo H, Kim HJ, Nam DH, Kim SH, Chun S, Joo KM, Park WY. Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with - Fusion. International Journal of Molecular Sciences. 20. PMID 30959925 DOI: 10.3390/Ijms20071717 |
0.313 |
|
| 2019 |
Shin YJ, Sa JK, Lee Y, Kim D, Chang N, Cho HJ, Son M, Oh MYT, Shin K, Lee JK, Park J, Jo YK, Kim M, Paddison PJ, Tergaonkar V, ... ... Nam DH, et al. PIP4K2A as a negative regulator of PI3K in PTENdeficient glioblastoma. The Journal of Experimental Medicine. PMID 30898893 DOI: 10.1084/Jem.20172170 |
0.406 |
|
| 2019 |
Jeon HY, Ham SW, Kim JK, Jin X, Lee SY, Shin YJ, Choi CY, Sa JK, Kim SH, Chun T, Jin X, Nam DH, Kim H. Ly6G inflammatory cells enable the conversion of cancer cells to cancer stem cells in an irradiated glioblastoma model. Cell Death and Differentiation. PMID 30804471 DOI: 10.1038/s41418-019-0282-0 |
0.319 |
|
| 2019 |
Lee J, Kim S, Nam D, Lee SJ, Park SH, Park JO, Lee J, Kim K, Lee H, Park N, Kim H, Lee S, Song S, Kim JJ, Park YS, et al. First-in-human phase I trial of anti-hepatocyte growth factor (HGF) antibody (YYB101) in refractory solid tumor patients: Integrative pathologic-genomic analysis and the final results. Journal of Clinical Oncology. 37: 3104-3104. DOI: 10.1200/Jco.2019.37.15_Suppl.3104 |
0.389 |
|
| 2019 |
Yun JW, Bae YK, Cho SY, Kim H, Nam D, Kim S, Chun S, Joo KM, Lee HW, Park W. Abstract 1723: Elucidation of novel therapeutic targets for acute myeloid leukemias with RUNX1-RUNX1T1 fusion Cancer Research. 79: 1723-1723. DOI: 10.1158/1538-7445.Sabcs18-1723 |
0.322 |
|
| 2019 |
Zhang J, Caruso FP, Sa JK, Justesen S, Nam D, Sims P, Ceccarelli M, Lasorella A, Iavarone A. Abstract LB-065: A high quality neoantigen fitness model cooperates with T lymphocyte infiltrates to identify glioblastoma patients with the longest survival Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Lb-065 |
0.405 |
|
| 2019 |
Cloughesy T, Petrecca K, Walbert T, Butowski N, Salacz M, Perry J, Damek D, Bota D, Bettegowda C, Zhu J, Iwamoto F, Placantonakis D, Martinez N, Elder JB, Kaptain G, ... ... Nam D, et al. LTBK-08. TOCA 511 & TOCA FC VERSUS STANDARD OF CARE IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA Neuro-Oncology. 21: vi284-vi284. DOI: 10.1093/Neuonc/Noz219.1199 |
0.332 |
|
| 2019 |
Hwan Kim K, Kim S, Lee J, Kong D, Jun Seol H, Nam D. RTHP-13. EFFICACY OF FRACTIONATED GAMMA KNIFE RADIOSURGERY FOR ORBITAL CAVERNOUS HEMANGIOMA: 10-YEAR EXPERIENCE AT A SINGLE INSTITUTION Neuro-Oncology. 21: vi212-vi213. DOI: 10.1093/Neuonc/Noz175.886 |
0.35 |
|
| 2019 |
Yamashita D, Minata M, Yu H, Zhang S, Li C, Flanary V, Ghosh S, Lee Y, Cho H, Botta D, Guo X, Ozaki S, Yamaguchi S, Komarova S, Bastola S, ... ... Nam D, et al. TMIC-12. TUMOR EDGE-DESTINED CELLS IN GBM CELLS IN A CELL-INTRINSIC MECHANISM Neuro-Oncology. 21: vi249-vi249. DOI: 10.1093/Neuonc/Noz175.1046 |
0.428 |
|
| 2019 |
Kim Y, Kim D, Lee K, Lim Y, Nam D. Preclinical in vivo screening to predict responder patients depend on EGFR status Annals of Oncology. 30. DOI: 10.1093/Annonc/Mdz268.023 |
0.375 |
|
| 2018 |
Jeon C, Hong CK, Woo KI, Hong SD, Nam DH, Lee JI, Choi JW, Seol HJ, Kong DS. Endoscopic transorbital surgery for Meckel's cave and middle cranial fossa tumors: surgical technique and early results. Journal of Neurosurgery. 1-10. PMID 30544350 DOI: 10.3171/2018.6.Jns181099 |
0.354 |
|
| 2018 |
Sa JK, Choi SW, Zhao J, Lee Y, Zhang J, Kong DS, Choi JW, Seol HJ, Lee JI, Iavarone A, Rabadan R, Nam DH. Hypermutagenesis in untreated adult gliomas due to inherited mismatch mutations. International Journal of Cancer. PMID 30536544 DOI: 10.1002/Ijc.32054 |
0.389 |
|
| 2018 |
Lee MH, Hong SD, Woo KI, Kim YD, Choi JW, Seol HJ, Lee JI, Shin HJ, Nam DH, Kong DS. Endoscopic endonasal vs. transorbital surgery for middle cranial fossa tumors: Comparison of clinical outcomes based on surgical corridors. World Neurosurgery. PMID 30468930 DOI: 10.1016/J.Wneu.2018.11.090 |
0.337 |
|
| 2018 |
Kim KH, Lee MH, Cho KR, Choi JW, Kong DS, Seol HJ, Nam DH, Lee JI. The influence of histology on the response of brain metastases to gamma knife radiosurgery: a propensity score-matched study. Acta Neurochirurgica. PMID 30413940 DOI: 10.1007/S00701-018-3726-2 |
0.347 |
|
| 2018 |
Kim BS, Kim ST, Kim JH, Seol HJ, Nam DH, Shin HJ, Lee JI, Kong DS. ADC value as a predictive biomarker for survival in patients with treatment-naïve glioblastoma using quantitative multiparametric MR profiling. World Neurosurgery. PMID 30391622 DOI: 10.1016/J.Wneu.2018.10.151 |
0.334 |
|
| 2018 |
Hu H, Mu Q, Bao Z, Chen Y, Liu Y, Chen J, Wang K, Wang Z, Nam Y, Jiang B, Sa JK, Cho HJ, Her NG, Zhang C, Zhao Z, ... ... Nam DH, et al. Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor. Cell. PMID 30343896 DOI: 10.1016/J.Cell.2018.09.038 |
0.407 |
|
| 2018 |
Jeon C, Hong SD, Seol HJ, Lee JI, Nam DH, Hwang YJ, Kong DS. Corrigendum to "Reconstructive outcome of intraoperative cerebrospinal fluid leak after endoscopic endonasal surgery for tumors involving skull base" [J. Clin. Neurosci. 45 (2017) 227-231]. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 30287251 DOI: 10.1016/J.Jocn.2018.03.001 |
0.311 |
|
| 2018 |
Lee JK, Liu Z, Sa JK, Shin S, Wang J, Bordyuh M, Cho HJ, Elliott O, Chu T, Choi SW, Rosenbloom DIS, Lee IH, Shin YJ, Kang HJ, Kim D, ... ... Nam DH, et al. Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy. Nature Genetics. PMID 30262818 DOI: 10.1038/S41588-018-0209-6 |
0.43 |
|
| 2018 |
Kong DS, Young SM, Hong CK, Kim YD, Hong SD, Choi JW, Seol HJ, Lee JI, Shin HJ, Nam DH, Woo KI. Clinical and ophthalmological outcome of endoscopic transorbital surgery for cranioorbital tumors. Journal of Neurosurgery. 1-9. PMID 30215555 DOI: 10.3171/2018.3.Jns173233 |
0.386 |
|
| 2018 |
Barnes JM, Kaushik S, Bainer RO, Sa JK, Woods EC, Kai F, Przybyla L, Lee M, Lee HW, Tung JC, Maller O, Barrett AS, Lu KV, Lakins JN, Hansen KC, ... ... Nam DH, et al. A tension-mediated glycocalyx-integrin feedback loop promotes mesenchymal-like glioblastoma. Nature Cell Biology. PMID 30202050 DOI: 10.1038/S41556-018-0183-3 |
0.333 |
|
| 2018 |
Lee YS, Choi JY, Lee J, Shim DM, Kim J, Park WY, Nam DH, Seo SW. TP53-dependence on the effect of doxorubicin and Src inhibitor combination therapy. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 40: 1010428318794217. PMID 30124118 DOI: 10.1177/1010428318794217 |
0.337 |
|
| 2018 |
Her NG, Oh JW, Oh YJ, Han S, Cho HJ, Lee Y, Ryu GH, Nam DH. Potent effect of the MDM2 inhibitor AMG232 on suppression of glioblastoma stem cells. Cell Death & Disease. 9: 792. PMID 30022047 DOI: 10.1038/S41419-018-0825-1 |
0.381 |
|
| 2018 |
Sa JK, Kim SH, Lee JK, Cho HJ, Shin YJ, Shin H, Koo H, Kim D, Lee M, Kang W, Hong SH, Kim JY, Park YW, Song SW, Lee SJ, ... ... Nam DH, et al. Identification of Genomic and Molecular Traits that Present Therapeutic Vulnerability to HGF-targeted therapy in Glioblastoma. Neuro-Oncology. PMID 29939324 DOI: 10.1093/Neuonc/Noy105 |
0.352 |
|
| 2018 |
Pavlyukov MS, Yu H, Bastola S, Minata M, Shender VO, Lee Y, Zhang S, Wang J, Komarova S, Wang J, Yamaguchi S, Alsheikh HA, Shi J, Chen D, Mohyeldin A, ... ... Nam DH, et al. Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors. Cancer Cell. PMID 29937354 DOI: 10.1016/J.Ccell.2018.05.012 |
0.402 |
|
| 2018 |
Kim KH, Kang SJ, Choi JW, Kong DS, Seol HJ, Nam DH, Lee JI. Clinical and radiological outcomes of proactive Gamma Knife surgery for asymptomatic meningiomas compared with the natural course without intervention. Journal of Neurosurgery. 1-10. PMID 29775154 DOI: 10.3171/2017.12.Jns171943 |
0.381 |
|
| 2018 |
Choi SW, Shin H, Sa JK, Cho HJ, Koo H, Kong DS, Seol HJ, Nam DH. Identification of transcriptome signature for predicting clinical response to bevacizumab in recurrent glioblastoma. Cancer Medicine. PMID 29573206 DOI: 10.1002/Cam4.1439 |
0.345 |
|
| 2018 |
Kim BS, Kim Y, Kong DS, Nam DH, Lee JI, Suh YL, Seol HJ. Clinical outcomes of intracranial solitary fibrous tumor and hemangiopericytoma: analysis according to the 2016 WHO classification of central nervous system tumors. Journal of Neurosurgery. 1-13. PMID 29372881 DOI: 10.3171/2017.7.Jns171226 |
0.42 |
|
| 2018 |
Lee HM, Lee E, Yeo SY, Shin S, Park HK, Nam DH, Kim SH. Drug repurposing screening identifies bortezomib and panobinostat as drugs targeting cancer associated fibroblasts (CAFs) by synergistic induction of apoptosis. Investigational New Drugs. PMID 29349597 DOI: 10.1007/S10637-017-0547-8 |
0.34 |
|
| 2018 |
Pavlyukov M, Bastola S, Yu H, Shender VO, Anufrieva K, Nam D, Nakano I. Tmic-41. Apoptotic Cells Promote Malignancy Of Surviving Glioblastoma Cells By Intercellular Transfer Of Splicing Factors Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.1100 |
0.316 |
|
| 2017 |
Lee DW, Lee SY, Doh I, Ryu GH, Nam DH. High-Dose Compound Heat Map for 3D-Cultured Glioblastoma Multiforme Cells in a Micropillar and Microwell Chip Platform. Biomed Research International. 2017: 7218707. PMID 29270434 DOI: 10.1155/2017/7218707 |
0.305 |
|
| 2017 |
Kim JY, Yu JH, Nam SJ, Kim SW, Lee SK, Park WY, Noh DY, Nam DH, Park YH, Han W, Lee JE. Genetic and Clinical Characteristics of Phyllodes Tumors of the Breast. Translational Oncology. 11: 18-23. PMID 29145046 DOI: 10.1016/J.Tranon.2017.10.002 |
0.329 |
|
| 2017 |
Park H, Kim D, Son E, Shin S, Sa JK, Kim SH, Yoon Y, Nam DH. Antitumor activity, pharmacokinetics, tumor-homing effect, and hepatotoxicity of a species cross-reactive c-Met antibody. Biochemical and Biophysical Research Communications. PMID 28917835 DOI: 10.1016/J.Bbrc.2017.09.061 |
0.309 |
|
| 2017 |
Park H, Kim D, Kim E, Sa JK, Lee HW, Yu S, Oh J, Kim SH, Yoon Y, Nam DH. Tumor Inhibitory Effect of IRCR201, a Novel Cross-Reactive c-Met Antibody Targeting the PSI Domain. International Journal of Molecular Sciences. 18. PMID 28902178 DOI: 10.3390/Ijms18091968 |
0.374 |
|
| 2017 |
Lee JH, Jeon YG, Lee KH, Lee HW, Park J, Jang H, Kang M, Lee HS, Cho HJ, Nam DH, Kwak C, Kim JB. RNF20 Suppresses Tumorigenesis by Inhibiting SREBP1c-PTTG1 Axis in Kidney Cancer. Molecular and Cellular Biology. PMID 28827316 DOI: 10.1128/Mcb.00265-17 |
0.373 |
|
| 2017 |
Jeon CM, Hong SD, Seol HJ, Lee JI, Nam DH, Hwang YJ, Kong DS. Reconstructive outcome of intraoperative cerebrospinal fluid leak after endoscopic endonasal surgery for tumors involving skull base. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 28765065 DOI: 10.1016/J.Jocn.2017.07.012 |
0.353 |
|
| 2017 |
Yin J, Oh YT, Kim JY, Kim SS, Choi E, Kim TH, Hong JH, Chang N, Cho HJ, Sa JK, Kim JC, Kwon HJ, Park S, Lin W, Nakano I, ... ... Nam DH, et al. Transglutaminase 2 inhibition reverses mesenchymal transdifferentiation of glioma stem cells by regulating C/EBPβ signaling. Cancer Research. PMID 28754668 DOI: 10.1158/0008-5472.Can-17-0388 |
0.383 |
|
| 2017 |
Ryu SM, Lee JI, Park K, Choi JW, Kong DS, Nam DH, Jeong HS, Cho YS, Seol HJ. Optimal treatment of jugular foramen schwannomas: long-term outcome of a multidisciplinary approach for a series of 29 cases in a single institute. Acta Neurochirurgica. PMID 28589468 DOI: 10.1007/S00701-017-3230-0 |
0.313 |
|
| 2017 |
Kim BS, Kong DS, Seol HJ, Nam DH, Lee JI. MGMT promoter methylation status as a prognostic factor for the outcome of gamma knife radiosurgery for recurrent glioblastoma. Journal of Neuro-Oncology. PMID 28536992 DOI: 10.1007/S11060-017-2478-9 |
0.307 |
|
| 2017 |
Chang N, Ahn SH, Kong DS, Lee HW, Nam DH. The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment. Molecular and Cellular Endocrinology. PMID 28089821 DOI: 10.1016/J.Mce.2017.01.004 |
0.433 |
|
| 2017 |
Lee MH, Kong DS, Seol HJ, Nam DH, Lee JI. The Influence of Biomarker Mutations and Systemic Treatment on Cerebral Metastases from NSCLC Treated with Radiosurgery. Journal of Korean Neurosurgical Society. 60: 21-29. PMID 28061489 DOI: 10.3340/Jkns.2016.0404.005 |
0.33 |
|
| 2017 |
Liu J, Cho YB, Hong Hk, Wu S, Ebert PJ, Bray SM, Wong SS, Ting JC, Calley JN, Whittington CF, Bhagwat S, Bowden E, Aggarwal A, Reinhard C, Wild R, ... Nam D, et al. Abstract 849: Molecular characterization of primary tumor & the paired liver metastatic biopsies of colorectal cancer reveals a critical role of immunosuppression, EMT & angiogenesis in cancer metastasis Cancer Research. 77: 849-849. DOI: 10.1158/1538-7445.Am2017-849 |
0.327 |
|
| 2017 |
Shin H, Sa J, Nam D. Csig-27. Patient-Derived Cell Originated Secretome Analysis Identifies Midkine As A Potent Therapeutic Target In Glioblastoma Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.221 |
0.391 |
|
| 2017 |
Han S, Shin K, Kang H, Lee J, Nam D. Cbio-28. Patient Gbm Cell Originated Secretome Analysis Identifies Cytokine A, As A Potent Therapeutic Target Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.146 |
0.343 |
|
| 2017 |
Wang Q, Hu B, Hu X, Squatrito M, Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, Barthel FP, Cho HJ, Lin Y, Satani N, Martinez-Ledesma E, Zheng S, ... ... Nam D, et al. TMIC-22. DECIPHERING GLIOMA INTRINSIC TRANSCRIPTIONAL SUBTYPES IDENTIFIES TUMOR EVOLUTION ASSOCIATES WITH CHANGES IN IMMUNE-MICROENVIRONMENT Neuro-Oncology. 19: vi247-vi248. DOI: 10.1093/Neuonc/Nox168.1011 |
0.332 |
|
| 2016 |
Sa JK, Lee IH, Hong SD, Kong DS, Nam DH. Genomic and transcriptomic characterization of skull base chordoma. Oncotarget. PMID 27901492 DOI: 10.18632/Oncotarget.13616 |
0.351 |
|
| 2016 |
Lee S, Seo SW, Hwang J, Seol HJ, Nam DH, Lee JI, Kong DS. Analysis of risk factors to predict communicating hydrocephalus following gamma knife radiosurgery for intracranial schwannoma. Cancer Medicine. PMID 27882725 DOI: 10.1002/Cam4.955 |
0.339 |
|
| 2016 |
Hwang J, Seol HJ, Nam DH, Lee JI, Lee MH, Kong DS. Therapeutic Strategy for Cavernous Sinus-Invading Non-Functioning Pituitary Adenomas Based on the Modified Knosp Grading System. Brain Tumor Research and Treatment. 4: 63-69. PMID 27867914 DOI: 10.14791/Btrt.2016.4.2.63 |
0.349 |
|
| 2016 |
Kim BS, Kong DS, Seol HJ, Nam DH, Lee JI. Gamma knife radiosurgery for residual or recurrent intracranial hemangiopericytomas. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 27769643 DOI: 10.1016/J.Jocn.2016.10.002 |
0.413 |
|
| 2016 |
Choi JW, Kong DS, Seol HJ, Nam DH, Yoo KH, Sun JM, Ahn JS, Ahn MJ, Park K, Lee JI. Outcomes of gamma knife radiosurgery in combination with crizotinib for patients with brain metastasis from non-small cell lung cancer. World Neurosurgery. PMID 27565474 DOI: 10.1016/J.Wneu.2016.08.046 |
0.348 |
|
| 2016 |
Chang N, Lee HW, Lim JE, Jeong DE, Song HJ, Kim S, Nam DH, Sung HH, Jeong BC, Seo SI, Jeon SS, Lee HM, Choi HY, Jeon HG. Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletion. Oncotarget. PMID 27438149 DOI: 10.18632/Oncotarget.10539 |
0.399 |
|
| 2016 |
You HJ, Park HY, Kim J, Lee IH, Seol HJ, Lee JI, Kim ST, Kong DS, Nam DH. Integrative radiogenomic analysis for genomic signatures in glioblastomas presenting leptomeningeal dissemination. Medicine. 95: e4109. PMID 27399113 DOI: 10.1097/Md.0000000000004109 |
0.363 |
|
| 2016 |
Lee KH, Nam H, Jeong DE, Kim SS, Song HJ, Pyeon HJ, Kang K, Hong SC, Nam DH, Joo KM. Sensitive Tumorigenic Potential Evaluation of Adult Human Multipotent Neural Cells Immortalized by hTERT Gene Transduction. Plos One. 11: e0158639. PMID 27391353 DOI: 10.1371/Journal.Pone.0158639 |
0.334 |
|
| 2016 |
Kim BS, Seol HJ, Nam DH, Park CK, Kim IH, Kim TM, Kim JH, Cho YH, Yoon SM, Chang JH, Kang SG, Kim EH, Suh CO, Jung TY, Lee KH, et al. Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 27384161 DOI: 10.4143/Crt.2015.473 |
0.335 |
|
| 2016 |
Kim BS, Seol HJ, Lee JI, Shin HJ, Park K, Kong DS, Nam DH, Cho YS. Clinical outcome of neurofibromatosis type 2-related vestibular schwannoma: treatment strategies and challenges. Neurosurgical Review. PMID 27142681 DOI: 10.1007/S10143-016-0728-5 |
0.343 |
|
| 2016 |
Kim KT, Lee HW, Lee HO, Song HJ, Jeong DE, Shin S, Kim H, Shin Y, Nam DH, Jeong BC, Kirsch DG, Joo KM, Park WY. Application of single-cell RNA sequencing in optimizing a combinatorial therapeutic strategy in metastatic renal cell carcinoma. Genome Biology. 17: 80. PMID 27139883 DOI: 10.1186/S13059-016-0945-9 |
0.367 |
|
| 2016 |
Lee JK, Nam DH, Lee J. Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges. Oncology Letters. 11: 1281-1286. PMID 26893731 DOI: 10.3892/Ol.2016.4074 |
0.406 |
|
| 2016 |
Kong DS, Kim J, Lee IH, Kim ST, Seol HJ, Lee JI, Park WY, Ryu G, Wang Z, Ma'ayan A, Nam DH. Integrative radiogenomic analysis for multicentric radiophenotype in glioblastoma. Oncotarget. PMID 26863628 DOI: 10.18632/Oncotarget.7115 |
0.381 |
|
| 2016 |
Toledo C, Yu D, Hoellerbauer P, Davis R, Basom R, Girard E, Corrin P, Bolouri H, Davison J, Zhang Q, Nam D, Lee J, Pollard S, Delrow J, Clurman B, et al. Abstract 4370: Genome-wide CRISPR-Cas9 screens reveal loss of redundancy between PKMYT1 and WEE1 in patient-derived glioblastoma stem-like cells Cancer Research. 76: 4370-4370. DOI: 10.1158/1538-7445.Am2016-4370 |
0.388 |
|
| 2016 |
Kim K, Lee HW, Lee H, Song HJ, Jeong DE, Shin S, Kim H, Shin Y, Nam D, Jeong BC, Kirsch DG, Joo KM, Park W. Abstract 165: Single-cell transcriptome analysis guides tailored combinatorial therapeutics in refractory kidney cancer Cancer Research. 76: 165-165. DOI: 10.1158/1538-7445.Am2016-165 |
0.419 |
|
| 2016 |
Wang Q, Hu X, Muller F, Kim H, Squatrito M, Mikkelsen T, Scarpace L, Barthel F, Lin Y, Satani N, Martinez-Ledesma E, Chang E, Olar A, Hu B, deCarvalho A, ... ... Nam D, et al. TMIC-14. TUMOR EVOLUTION OF GLIOMA INTRINSIC GENE EXPRESSION SUBTYPE ASSOCIATES WITH IMMUNOLOGICAL CHANGES IN THE MICROENVIRONMENT Neuro-Oncology. 18: vi202-vi202. DOI: 10.1093/Neuonc/Now212.854 |
0.348 |
|
| 2015 |
Lee SJ, Kang WY, Yoon Y, Jin JY, Song HJ, Her JH, Kang SM, Hwang YK, Kang KJ, Joo KM, Nam DH. Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain. Bmc Cancer. 15: 1011. PMID 26704632 DOI: 10.1186/S12885-015-2034-Y |
0.351 |
|
| 2015 |
Lee HW, Lee K, Kim DG, Yang H, Nam DH. Facilitating tailored therapeutic strategies for glioblastoma through an orthotopic patient-derived xenograft platform. Histology and Histopathology. 11695. PMID 26578300 DOI: 10.14670/Hh-11-695 |
0.368 |
|
| 2015 |
Lee Y, Kim KH, Kim DG, Cho HJ, Kim Y, Rheey J, Shin K, Seo YJ, Choi YS, Lee JI, Lee J, Joo KM, Nam DH. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2. Plos One. 10: e0137703. PMID 26444992 DOI: 10.1371/journal.pone.0137703 |
0.325 |
|
| 2015 |
Jeong DE, Song HJ, Lim S, Lee SJ, Lim JE, Nam DH, Joo KM, Jeong BC, Jeon SS, Choi HY, Lee HW. Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis. Oncotarget. PMID 26426994 DOI: 10.18632/Oncotarget.5422 |
0.39 |
|
| 2015 |
Cho KR, Lee MH, Kong DS, Seol HJ, Nam DH, Sun JM, Ahn JS, Ahn MJ, Park K, Kim ST, Lim DH, Lee JI. Outcome of gamma knife radiosurgery for metastatic brain tumors derived from non-small cell lung cancer. Journal of Neuro-Oncology. PMID 26373297 DOI: 10.1007/S11060-015-1915-X |
0.419 |
|
| 2015 |
Kim J, Lee IH, Cho HJ, Park CK, Jung YS, Kim Y, Nam SH, Kim BS, Johnson MD, Kong DS, Seol HJ, Lee JI, Joo KM, Yoon Y, Park WY, ... ... Nam DH, et al. Spatiotemporal Evolution of the Primary Glioblastoma Genome. Cancer Cell. 28: 318-28. PMID 26373279 DOI: 10.1016/J.Ccell.2015.07.013 |
0.3 |
|
| 2015 |
Kang W, Kim SH, Cho HJ, Jin J, Lee J, Joo KM, Nam DH. Talin1 targeting potentiates anti-angiogenic therapy by attenuating invasion and stem-like features of Glioblastoma multiforme. Oncotarget. PMID 26336988 DOI: 10.18632/Oncotarget.4835 |
0.385 |
|
| 2015 |
Kim DG, Jin Y, Jin J, Yang H, Joo KM, Lee WS, Shim SR, Kim SW, Yoo J, Lee SH, Yoo JS, Nam DH. Anticancer activity of TTAC-0001, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) monoclonal antibody, is associated with inhibition of tumor angiogenesis. Mabs. 0. PMID 26325365 DOI: 10.1080/19420862.2015.1086854 |
0.392 |
|
| 2015 |
Choi JW, Im YS, Kong DS, Seol HJ, Nam DH, Lee JI. Effectiveness of Postoperative Gamma Knife Radiosurgery to the Tumor Bed after Resection of Brain Metastases. World Neurosurgery. PMID 26211856 DOI: 10.1016/J.Wneu.2015.07.045 |
0.376 |
|
| 2015 |
Kong DS, Kim HR, Choi YR, Seol HJ, Lee JI, Nam DH. Prognostic impact of molecular phenotype in patients with recurrent anaplastic glioma treated with prolonged administration of temozolomide. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 26138051 DOI: 10.1016/J.Jocn.2015.02.036 |
0.366 |
|
| 2015 |
Kim KT, Lee HW, Lee HO, Kim SC, Seo YJ, Chung W, Eum HH, Nam DH, Kim J, Joo KM, Park WY. Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells. Genome Biology. 16: 127. PMID 26084335 DOI: 10.1186/S13059-015-0692-3 |
0.42 |
|
| 2015 |
Oh BY, Lee WY, Jung S, Hong HK, Nam DH, Park YA, Huh JW, Yun SH, Kim HC, Chun HK, Cho YB. Correlation between tumor engraftment in patient-derived xenograft models and clinical outcomes in colorectal cancer patients. Oncotarget. 6: 16059-68. PMID 25965827 DOI: 10.18632/Oncotarget.3863 |
0.387 |
|
| 2015 |
Lee HW, Choi HY, Joo KM, Nam DH. Tumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancer. International Journal of Molecular Sciences. 16: 4471-91. PMID 25723737 DOI: 10.3390/Ijms16034471 |
0.398 |
|
| 2015 |
Noh JH, Lee MH, Kim WS, Lim do H, Kim ST, Kong DS, Nam DH, Lee JI, Seol HJ. Optimal treatment of leptomeningeal spread in glioblastoma: analysis of risk factors and outcome. Acta Neurochirurgica. 157: 569-76. PMID 25663100 DOI: 10.1007/S00701-015-2344-5 |
0.407 |
|
| 2015 |
Nam H, Lee KH, Nam DH, Joo KM. Adult human neural stem cell therapeutics: Current developmental status and prospect. World Journal of Stem Cells. 7: 126-36. PMID 25621112 DOI: 10.4252/Wjsc.V7.I1.126 |
0.32 |
|
| 2015 |
Kim HR, Kim KH, Kong DS, Seol HJ, Nam DH, Lim do H, Lee JI. Outcome of salvage treatment for recurrent glioblastoma. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 22: 468-73. PMID 25595963 DOI: 10.1016/J.Jocn.2014.09.018 |
0.3 |
|
| 2015 |
Lee HW, Lee JI, Lee SJ, Cho HJ, Song HJ, Jeong da E, Seo YJ, Shin S, Joung JG, Kwon YJ, Choi YL, Park WY, Lee HM, Seol HJ, Shim YM, ... ... Nam DH, et al. Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1172-82. PMID 25549722 DOI: 10.1158/1078-0432.Ccr-14-1589 |
0.348 |
|
| 2015 |
Kim HR, Kim SH, Lee JI, Seol HJ, Nam DH, Kim ST, Park K, Kim JH, Kong DS. Outcome of radiosurgery for recurrent malignant gliomas: assessment of treatment response using relative cerebral blood volume. Journal of Neuro-Oncology. 121: 311-8. PMID 25488072 DOI: 10.1007/S11060-014-1634-8 |
0.327 |
|
| 2015 |
Kim K, Lee J, Park D, Nam D, Lee H, Park W. Abstract 3748: Transcriptome landscape of brain tumor progression at single-cell resolution Cancer Research. 75: 3748-3748. DOI: 10.1158/1538-7445.Am2015-3748 |
0.436 |
|
| 2015 |
Ding Y, Toledo C, Hoellerbauer P, Basom R, Girad E, Lee E, Corrin P, Lin Q, Li X, Nam D, Lee J, Zhu J, Pollard S, Delrow J, Olson J, et al. Abstract 1106: Genome-wide CRISPR-Cas9 screens reveal candidate therapeutic targets and tumor suppressor genes for human glioma Cancer Research. 75: 1106-1106. DOI: 10.1158/1538-7445.Am2015-1106 |
0.423 |
|
| 2015 |
Toledo CM, Ding Y, Hoellerbauer P, Davis RJ, Basom R, Girard EJ, Lee E, Corrin P, Bolouri H, Davison J, Zhang Q, Nam D, Lee J, Pollard SM, Zhu J, et al. Abstract C159: Genome-wide CRISPR-Cas9 screens uncover therapeutic targets and tumor suppressor genes in glioblastoma multiforme Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-C159 |
0.404 |
|
| 2015 |
Kim IA, Yu T, Kang H, Lim DH, Kim IH, Chung W, Suh C, Choi BO, Cho KH, Cho JH, Kim JH, Nam D, Park C, Hong Y. Hcp-13Pattern Of Care And Outcome Of Anaplastic Oligodendrogliomaand Oligoastrocytoma In A Korean Population: The Korean Radiation Oncology Group Study 13-12 Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov216.13 |
0.363 |
|
| 2014 |
Jee TK, Seol HJ, Im YS, Kong DS, Nam DH, Park K, Shin HJ, Lee JI. Fractionated gamma knife radiosurgery for benign perioptic tumors: outcomes of 38 patients in a single institute. Brain Tumor Research and Treatment. 2: 56-61. PMID 25408926 DOI: 10.14791/Btrt.2014.2.2.56 |
0.334 |
|
| 2014 |
Yeom SY, Nam DH, Park C. RRAD promotes EGFR-mediated STAT3 activation and induces temozolomide resistance of malignant glioblastoma. Molecular Cancer Therapeutics. 13: 3049-61. PMID 25313011 DOI: 10.1158/1535-7163.Mct-14-0244 |
0.368 |
|
| 2014 |
Woo SR, Ham Y, Kang W, Yang H, Kim S, Jin J, Joo KM, Nam DH. KML001, a telomere-targeting drug, sensitizes glioblastoma cells to temozolomide chemotherapy and radiotherapy through DNA damage and apoptosis. Biomed Research International. 2014: 747415. PMID 25295271 DOI: 10.1155/2014/747415 |
0.406 |
|
| 2014 |
Lee DW, Choi YS, Seo YJ, Lee MY, Jeon SY, Ku B, Nam DH. High-throughput, miniaturized clonogenic analysis of a limiting dilution assay on a micropillar/microwell chip with brain tumor cells. Small (Weinheim An Der Bergstrasse, Germany). 10: 5098-105. PMID 25227876 DOI: 10.1002/Smll.201401074 |
0.326 |
|
| 2014 |
Choi SH, Yang H, Lee SH, Ki JH, Nam DH, Yoo HY. TopBP1 and Claspin contribute to the radioresistance of lung cancer brain metastases. Molecular Cancer. 13: 211. PMID 25216549 DOI: 10.1186/1476-4598-13-211 |
0.368 |
|
| 2014 |
Oh YT, Cho HJ, Kim J, Lee JH, Rho K, Seo YJ, Choi YS, Jung HJ, Song HS, Kong DS, Seol HJ, Lee JI, Yoon Y, Kim S, Nam DH, et al. Translational validation of personalized treatment strategy based on genetic characteristics of glioblastoma. Plos One. 9: e103327. PMID 25084005 DOI: 10.1371/Journal.Pone.0103327 |
0.387 |
|
| 2014 |
Xie T, Cho YB, Wang K, Huang D, Hong HK, Choi YL, Ko YH, Nam DH, Jin J, Yang H, Fernandez J, Deng S, Rejto PA, Lee WY, Mao M. Patterns of somatic alterations between matched primary and metastatic colorectal tumors characterized by whole-genome sequencing. Genomics. 104: 234-41. PMID 25066378 DOI: 10.1016/J.Ygeno.2014.07.012 |
0.393 |
|
| 2014 |
Choi Y, Lim do H, Jo K, Nam DH, Seol HJ, Lee JI. Efficacy of postoperative radiotherapy for high grade meningiomas. Journal of Neuro-Oncology. 119: 405-12. PMID 24965339 DOI: 10.1007/S11060-014-1507-1 |
0.341 |
|
| 2014 |
Kim J, Lee Y, Cho HJ, Cho HJ, Lee YE, An J, Cho GH, Ko YH, Joo KM, Nam DH. NTRK1 fusion in glioblastoma multiforme. Plos One. 9: e91940. PMID 24647444 DOI: 10.1371/Journal.Pone.0091940 |
0.393 |
|
| 2014 |
Oh SW, Jee TK, Kong DS, Nam DH, Lee JI, Seol HJ. Outcome of conventional treatment and prognostic factor in elderly glioblastoma patients. Acta Neurochirurgica. 156: 641-51. PMID 24553726 DOI: 10.1007/S00701-014-2020-1 |
0.34 |
|
| 2014 |
Cho YB, Hong HK, Choi YL, Oh E, Joo KM, Jin J, Nam DH, Ko YH, Lee WY. Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors. The Journal of Surgical Research. 187: 502-9. PMID 24332554 DOI: 10.1016/J.Jss.2013.11.010 |
0.426 |
|
| 2014 |
Lee DW, Choi YS, Seo YJ, Lee MY, Jeon SY, Ku B, Kim S, Yi SH, Nam DH. High-throughput screening (HTS) of anticancer drug efficacy on a micropillar/microwell chip platform. Analytical Chemistry. 86: 535-42. PMID 24199994 DOI: 10.1021/Ac402546B |
0.399 |
|
| 2014 |
Bang Y, Su W, Nam D, Lim W, Bauer TM, Brana I, Poon RT, Hong DS, Lin C, Peng B, Zhang Y, Zhao S, Kumar A, Akimov M, Ma B. Phase I study of the safety and efficacy of INC280 in patients with advanced MET-dependent solid tumors. Journal of Clinical Oncology. 32: 2520-2520. DOI: 10.1200/Jco.2014.32.15_Suppl.2520 |
0.361 |
|
| 2014 |
Kim K, Lee H, Joo KM, Kim S, Lee J, Chang N, Sa JK, Cho YJ, Nam D, Lee H, Park W. Abstract 4664: Single-cell transcriptome analysis on lung squamous cell carcinoma derived from a patient Cancer Research. 74: 4664-4664. DOI: 10.1158/1538-7445.Am2014-4664 |
0.357 |
|
| 2014 |
Nam D, Kim J, Cho HJ, Lee I, Kong D, Seol HJ, Lee J, Park W. EVOLUTION OF THE GLIOBLASTOMA GENOME IN RESPONSE TO TREATMENTS Neuro-Oncology. 16: iii45-iii46. DOI: 10.1093/Neuonc/Nou209.15 |
0.423 |
|
| 2013 |
Jo KI, Im YH, Kong DS, Seol HJ, Nam DH, Lee JI. Gamma knife radiosurgery for brain metastases from breast cancer. Journal of Korean Neurosurgical Society. 54: 399-404. PMID 24379946 DOI: 10.3340/Jkns.2013.54.5.399 |
0.3 |
|
| 2013 |
Lee HW, Park YM, Lee SJ, Cho HJ, Kim DH, Lee JI, Kang MS, Seol HJ, Shim YM, Nam DH, Kim HH, Joo KM. Alpha-smooth muscle actin (ACTA2) is required for metastatic potential of human lung adenocarcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 5879-89. PMID 23995859 DOI: 10.1158/1078-0432.Ccr-13-1181 |
0.329 |
|
| 2013 |
Lee MH, Kong DS, Seol HJ, Nam DH, Lee JI. Risk of seizure and its clinical implication in the patients with cerebral metastasis from lung cancer. Acta Neurochirurgica. 155: 1833-7. PMID 23982228 DOI: 10.1007/S00701-013-1826-6 |
0.319 |
|
| 2013 |
Lee HW, Joo KM, Lim JE, Cho HJ, Cho HJ, Park MC, Seol HJ, Seo SI, Lee JI, Kim S, Jeong BC, Nam DH. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma. Molecular Cancer Research : McR. 11: 1375-86. PMID 23982215 DOI: 10.1158/1541-7786.Mcr-13-0101-T |
0.396 |
|
| 2013 |
Kang W, Seol HJ, Seong DH, Kim J, Kim Y, Kim SU, Nam DH, Joo KM. Adenosine potentiates the therapeutic effects of neural stem cells expressing cytosine deaminase against metastatic brain tumors. Oncology Reports. 30: 1101-6. PMID 23828015 DOI: 10.3892/Or.2013.2584 |
0.541 |
|
| 2013 |
Kim E, Kim M, Woo DH, Shin Y, Shin J, Chang N, Oh YT, Kim H, Rheey J, Nakano I, Lee C, Joo KM, Rich JN, Nam DH, Lee J. Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Cancer Cell. 23: 839-52. PMID 23684459 DOI: 10.1016/J.Ccr.2013.04.008 |
0.321 |
|
| 2013 |
Lee SJ, Seol HJ, Lee HW, Kang WY, Kang BG, Jin J, Jo MY, Jin Y, Lee JI, Joo KM, Nam DH. Gene silencing of c-Met leads to brain metastasis inhibitory effects. Clinical & Experimental Metastasis. 30: 845-54. PMID 23625089 DOI: 10.1007/S10585-013-9584-7 |
0.376 |
|
| 2013 |
Yang H, Lee HW, Kim Y, Lee Y, Choi YS, Kim KH, Jin J, Lee J, Joo KM, Nam DH. Radiosensitization of brain metastasis by targeting c-MET. Laboratory Investigation; a Journal of Technical Methods and Pathology. 93: 344-53. PMID 23381625 DOI: 10.1038/Labinvest.2012.180 |
0.526 |
|
| 2013 |
Joo KM, Kim J, Jin J, Kim M, Seol HJ, Muradov J, Yang H, Choi YL, Park WY, Kong DS, Lee JI, Ko YH, Woo HG, Lee J, Kim S, ... Nam DH, et al. Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ. Cell Reports. 3: 260-73. PMID 23333277 DOI: 10.1016/J.Celrep.2012.12.013 |
0.312 |
|
| 2013 |
Lee SJ, Lee JI, Nam DH, Ahn YC, Han JH, Sun JM, Ahn JS, Park K, Ahn MJ. Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 8: 185-91. PMID 23328548 DOI: 10.1097/Jto.0B013E3182773F21 |
0.367 |
|
| 2013 |
Lee D, Suh Y, Park T, Do I, Seol HJ, Nam D, Kim ST. Prognostic significance of tetraspanin CD151 in newly diagnosed glioblastomas. Journal of Surgical Oncology. 107: 646-652. PMID 22926763 DOI: 10.1002/Jso.23249 |
0.306 |
|
| 2013 |
Lee HW, Lee SJ, Song MY, Joo KM, Jeong BC, Nam D. Abstract C53: Tumor progression locus 2 (Tpl2) protein kinase contributes tumor growth and metastasis of renal cell carcinoma Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-C53 |
0.411 |
|
| 2013 |
Lee HW, Lee SJ, Song MY, Joo KM, Nam D. Abstract B100: Genomic copy number alterations associated with the early brain metastasis of non-small cell lung cancer Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-B100 |
0.356 |
|
| 2013 |
Oh YTM, Kim E, Lee J, Nam D. Abstract LB-270: Targeting USP1 decreases glioblastoma stem cell survival and tumor growth. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-270 |
0.441 |
|
| 2013 |
Kim J, Cho H, Cho G, Ko Y, Paik S, Nam D. Abstract 1765: Recurrent fusion of NTRK1 in glioblastoma multiforme. Cancer Research. 73: 1765-1765. DOI: 10.1158/1538-7445.Am2013-1765 |
0.38 |
|
| 2012 |
Jo KI, Im YS, Kong DS, Seol HJ, Nam DH, Kim YD, Lee JI. Multisession Gamma Knife surgery for benign orbital tumors. Journal of Neurosurgery. 117: 102-7. PMID 23205796 DOI: 10.3171/2012.7.Gks12780 |
0.342 |
|
| 2012 |
Lee HW, Seol HJ, Choi YL, Ju HJ, Joo KM, Ko YH, Lee JI, Nam DH. Genomic copy number alterations associated with the early brain metastasis of non-small cell lung cancer. International Journal of Oncology. 41: 2013-20. PMID 23076643 DOI: 10.3892/Ijo.2012.1663 |
0.31 |
|
| 2012 |
Park HY, Seol HJ, Nam DH, Lee JI, Kong DS, Kim JH, Park K. Treatment outcomes after surgical resection of midline anterior skull base meningiomas at a single center. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 19: 1654-8. PMID 23062794 DOI: 10.1016/J.Jocn.2011.11.044 |
0.313 |
|
| 2012 |
Hwang SJ, Seol HJ, Park YM, Kim KH, Gorospe M, Nam D, Kim HH. MicroRNA-146a suppresses metastatic activity in brain metastasis. Molecules and Cells. 34: 329-334. PMID 22949171 DOI: 10.1007/S10059-012-0171-6 |
0.341 |
|
| 2012 |
Joo KM, Jin J, Kim E, Ho Kim K, Kim Y, Gu Kang B, Kang YJ, Lathia JD, Cheong KH, Song PH, Kim H, Seol HJ, Kong DS, Lee JI, Rich JN, ... ... Nam DH, et al. MET signaling regulates glioblastoma stem cells. Cancer Research. 72: 3828-38. PMID 22617325 DOI: 10.1158/0008-5472.Can-11-3760 |
0.499 |
|
| 2012 |
Jo KI, Lim DH, Kim ST, Im YS, Kong DS, Seol HJ, Nam DH, Lee JI. Leptomeningeal seeding in patients with brain metastases treated by gamma knife radiosurgery. Journal of Neuro-Oncology. 109: 293-9. PMID 22610938 DOI: 10.1007/S11060-012-0892-6 |
0.361 |
|
| 2012 |
Lee MH, Kim SH, Seoul HJ, Nam DH, Lee JI, Park K, Kim JH, Kong DS. Impact of maximal safe resection on the clinical outcome of adults with craniopharyngiomas. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 19: 1005-8. PMID 22595354 DOI: 10.1016/J.Jocn.2011.09.033 |
0.361 |
|
| 2012 |
Cho YJ, Song HS, Bhang S, Lee S, Kang BG, Lee JC, An J, Cha CI, Nam DH, Kim BS, Joo KM. Therapeutic effects of human adipose stem cell-conditioned medium on stroke. Journal of Neuroscience Research. 90: 1794-802. PMID 22535477 DOI: 10.1002/Jnr.23063 |
0.316 |
|
| 2012 |
Choi JW, Lee JW, Kim JK, Jeon HK, Choi JJ, Kim DG, Kim BG, Nam DH, Kim HJ, Yun SH, Kim S. Splicing variant of AIMP2 as an effective target against chemoresistant ovarian cancer. Journal of Molecular Cell Biology. 4: 164-73. PMID 22532625 DOI: 10.1093/Jmcb/Mjs018 |
0.349 |
|
| 2012 |
Jo MY, Kim YG, Kim Y, Lee SJ, Kim MH, Joo KM, Kim HH, Nam DH. Combined therapy of temozolomide and ZD6474 (vandetanib) effectively reduces glioblastoma tumor volume through anti-angiogenic and anti-proliferative mechanisms. Molecular Medicine Reports. 6: 88-92. PMID 22505191 DOI: 10.3892/Mmr.2012.868 |
0.565 |
|
| 2012 |
Lee D, Kang SY, Suh YL, Jeong JY, Lee JI, Nam DH. Clinicopathologic and genomic features of gliosarcomas. Journal of Neuro-Oncology. 107: 643-50. PMID 22270848 DOI: 10.1007/S11060-011-0790-3 |
0.303 |
|
| 2012 |
Jung Y, Joo KM, Seong DH, Choi YL, Kong DS, Kim Y, Kim MH, Jin J, Suh YL, Seol HJ, Shin CS, Lee JI, Kim JH, Song SY, Nam DH. Identification of prognostic biomarkers for glioblastomas using protein expression profiling. International Journal of Oncology. 40: 1122-32. PMID 22179774 DOI: 10.3892/Ijo.2011.1302 |
0.495 |
|
| 2012 |
Kim Y, Kim KH, Lee J, Lee YA, Kim M, Lee SJ, Park K, Yang H, Jin J, Joo KM, Lee J, Nam DH. Wnt activation is implicated in glioblastoma radioresistance. Laboratory Investigation; a Journal of Technical Methods and Pathology. 92: 466-73. PMID 22083670 DOI: 10.1038/Labinvest.2011.161 |
0.525 |
|
| 2012 |
Yang H, Jin J, Kim M, Kim KH, Kim D, Kang W, Lee H, Joo KM, Nam D. Abstract 3460: Inhibition of c-met radio-sensitizes in breast cancer brain metastatic cancer Cancer Research. 72: 3460-3460. DOI: 10.1158/1538-7445.Am2012-3460 |
0.359 |
|
| 2012 |
Kim Y, Kim KH, Lee H, Yang H, Kim D, Kang W, Jin J, Joo KM, Lee J, Nam D. Abstract 3458: Wnt activation is implicated in glioblastoma radioresistance Cancer Research. 72: 3458-3458. DOI: 10.1158/1538-7445.Am2012-3458 |
0.581 |
|
| 2011 |
Seol HJ, Yoo HY, Jin J, Joo KM, Kim HS, Yoon SJ, Choi SH, Kim Y, Pyo HR, Lim DH, Kim W, Um HD, Kim JH, Lee JI, Nam DH. The expression of DNA damage checkpoint proteins and prognostic implication in metastatic brain tumors. Oncology Research. 19: 381-90. PMID 22329197 DOI: 10.3727/096504011X13123323849654 |
0.492 |
|
| 2011 |
Kim JY, Kim ST, Nam DH, Lee JI, Park K, Kong DS. Leukoencephalopathy and disseminated necrotizing leukoencephalopathy following intrathecal methotrexate chemotherapy and radiation therapy for central nerve system lymphoma or leukemia. Journal of Korean Neurosurgical Society. 50: 304-10. PMID 22200011 DOI: 10.3340/Jkns.2011.50.4.304 |
0.305 |
|
| 2011 |
Jin J, Bae KH, Yang H, Lee SJ, Kim H, Kim Y, Joo KM, Seo SW, Park TG, Nam DH. In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles. Bioconjugate Chemistry. 22: 2568-72. PMID 22070554 DOI: 10.1021/bc200406n |
0.48 |
|
| 2011 |
Jeon C, Kim S, Shin HJ, Nam DH, Lee JI, Park K, Kim JH, Jeon B, Kong DS. The therapeutic efficacy of fractionated radiotherapy and gamma-knife radiosurgery for craniopharyngiomas. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 18: 1621-5. PMID 22015100 DOI: 10.1016/J.Jocn.2011.03.028 |
0.403 |
|
| 2011 |
Seol HJ, Jin J, Seong DH, Joo KM, Kang W, Yang H, Kim J, Shin CS, Kim Y, Kim KH, Kong DS, Lee JI, Aboody KS, Lee HJ, Kim SU, ... Nam DH, et al. Genetically engineered human neural stem cells with rabbit carboxyl esterase can target brain metastasis from breast cancer. Cancer Letters. 311: 152-9. PMID 21868150 DOI: 10.1016/J.Canlet.2011.07.001 |
0.557 |
|
| 2011 |
Seol HJ, Yoo HY, Jin J, Joo KM, Kong DS, Yoon SJ, Yang H, Kang W, Lim DH, Park K, Kim JH, Lee JI, Nam DH. Prognostic implications of the DNA damage response pathway in glioblastoma. Oncology Reports. 26: 423-30. PMID 21617879 DOI: 10.3892/Or.2011.1325 |
0.385 |
|
| 2011 |
Jo KW, Shin HJ, Nam DH, Lee JI, Park K, Kim JH, Kong DS. Efficacy of endoport-guided endoscopic resection for deep-seated brain lesions. Neurosurgical Review. 34: 457-63. PMID 21614427 DOI: 10.1007/S10143-011-0319-4 |
0.309 |
|
| 2011 |
Yin J, Kim JK, Moon JH, Beck S, Piao D, Jin X, Kim SH, Lim YC, Nam DH, You S, Kim H, Choi YJ. hMSC-mediated concurrent delivery of endostatin and carboxylesterase to mouse xenografts suppresses glioma initiation and recurrence. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 1161-9. PMID 21386822 DOI: 10.1038/Mt.2011.28 |
0.331 |
|
| 2011 |
Yang H, Yoon SJ, Jin J, Choi SH, Seol HJ, Lee J, Nam D, Yoo HY. Inhibition of checkpoint kinase 1 sensitizes lung cancer brain metastases to radiotherapy. Biochemical and Biophysical Research Communications. 406: 53-58. PMID 21291864 DOI: 10.1016/J.Bbrc.2011.01.106 |
0.345 |
|
| 2011 |
Kim JA, Kim SJ, Do IG, Jin J, Nam DH, Ko YH, Kim K, Kim WS. Hypoxia-associated protein expression in primary central nervous system diffuse large B-cell lymphoma: does it predict prognosis? Leukemia & Lymphoma. 52: 205-13. PMID 21281236 DOI: 10.3109/10428194.2010.542261 |
0.302 |
|
| 2011 |
Lee SH, Kong DS, Seol HJ, Nam D, Lee J. Ventriculoperitoneal shunt for hydrocephalus caused by central nervous system metastasis. Journal of Neuro-Oncology. 104: 545-551. PMID 21274592 DOI: 10.1007/S11060-010-0512-2 |
0.383 |
|
| 2011 |
Lee SJ, Kim Y, Jo MY, Kim HS, Jin Y, Kim SU, Jin J, Joo KM, Nam DH. Combined treatment of tumor-tropic human neural stem cells containing the CD suicide gene effectively targets brain tumors provoking a mild immune response. Oncology Reports. 25: 63-8. PMID 21109958 DOI: 10.3892/Or_00001042 |
0.563 |
|
| 2011 |
Jin J, Joo KM, Lee SJ, Jo MY, Kim Y, Jin Y, Kim JK, Ahn JM, Yoon MJ, Lim J, Nam DH. Synergistic therapeutic effects of cytokine-induced killer cells and temozolomide against glioblastoma. Oncology Reports. 25: 33-9. PMID 21109954 DOI: 10.3892/Or_00001038 |
0.564 |
|
| 2011 |
Sung CO, Kim SC, Karnan S, Karube K, Shin HJ, Nam DH, Suh YL, Kim SH, Kim JY, Kim SJ, Kim WS, Seto M, Ko YH. Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma Blood. 117: 1291-1300. PMID 21088137 DOI: 10.1182/Blood-2010-07-297861 |
0.313 |
|
| 2011 |
Seol HJ, Nam D, Lee YJ, Smith CA, Rutka JT. Abstract 2355: Full-length wild-type CD99 increases the migration and invasiveness of human malignant glioma cells Cancer Research. 71: 2355-2355. DOI: 10.1158/1538-7445.Am2011-2355 |
0.369 |
|
| 2011 |
Jin J, Lee WS, Joo KM, Maiti KK, Biswas G, Kim W, Kim KT, Lee SJ, Kim KH, Nam DH, Chung SK. Preparation of blood-brain barrier-permeable paclitaxel-carrier conjugate and its chemotherapeutic activity in the mouse glioblastoma model Medchemcomm. 2: 270-273. DOI: 10.1039/C0Md00235F |
0.346 |
|
| 2010 |
Jin J, Joo KM, Nam Y, Kim DH, Lee SJ, Jo MY, Jin Y, Kim HS, Seo SW, Kim SJ, Nam DH, Kim WS. Schedule-dependent synergistic effect of rituximab on methotrexate chemotherapy against lymphoma of the central nervous system. Experimental and Therapeutic Medicine. 1: 943-946. PMID 22993623 DOI: 10.3892/Etm.2010.143 |
0.357 |
|
| 2010 |
Kim CK, Nguyen TL, Joo KM, Nam DH, Park J, Lee KH, Cho SW, Ahn JY. Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors. Cancer Research. 70: 9730-41. PMID 21098709 DOI: 10.1158/0008-5472.Can-10-1882 |
0.323 |
|
| 2010 |
Kim M, Koh YJ, Kim KE, Koh BI, Nam DH, Alitalo K, Kim I, Koh GY. CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche Cancer Research. 70: 10411-10421. PMID 21056990 DOI: 10.1158/0008-5472.Can-10-2591 |
0.372 |
|
| 2010 |
Park HJ, Kim JK, Jeon HM, Oh SY, Kim SH, Nam DH, Kim H. The neural stem cell fate determinant TLX promotes tumorigenesis and genesis of cells resembling glioma stem cells. Molecules and Cells. 30: 403-8. PMID 20814749 DOI: 10.1007/S10059-010-0122-Z |
0.365 |
|
| 2010 |
Jo K, Park H, Nam D, Lee J, Kong D, Park K, Kim JH. Treatment of atypical meningioma. Journal of Clinical Neuroscience. 17: 1362-1366. PMID 20800497 DOI: 10.1016/J.Jocn.2010.03.036 |
0.386 |
|
| 2010 |
Kong DS, Kim ST, Lee JI, Suh YL, Lim DH, Kim WS, Kwon KH, Park K, Kim JH, Nam DH. Impact of adjuvant chemotherapy for gliomatosis cerebri. Bmc Cancer. 10: 424. PMID 20704759 DOI: 10.1186/1471-2407-10-424 |
0.353 |
|
| 2010 |
Kong DS, Lee JI, Kim JH, Kim ST, Kim WS, Suh YL, Dong SM, Nam DH. Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma. Neuro-Oncology. 12: 289-96. PMID 20167817 DOI: 10.1093/Neuonc/Nop030 |
0.328 |
|
| 2010 |
Jin Y, Jin J, Joo KM, Lee SJ, Jo M, Kim Y, Nam D. Abstract LB-326: Synergistic therapeutic effects of cytokine-induced killer (CIK) cell and temozolomide against glioblastoma Immunology. 70. DOI: 10.1158/1538-7445.Am10-Lb-326 |
0.492 |
|
| 2009 |
Kim Y, Joo KM, Jin J, Nam DH. Cancer stem cells and their mechanism of chemo-radiation resistance. International Journal of Stem Cells. 2: 109-14. PMID 24855529 DOI: 10.15283/Ijsc.2009.2.2.109 |
0.526 |
|
| 2009 |
Rhee DJ, Kong DS, Kim WS, Park KB, Lee JI, Suh YL, Song SY, Kim ST, Lim DH, Park K, Kim JH, Nam DH. Efficacy of temozolomide as adjuvant chemotherapy after postsurgical radiotherapy alone for glioblastomas. Clinical Neurology and Neurosurgery. 111: 748-51. PMID 19716649 DOI: 10.1016/J.Clineuro.2009.07.014 |
0.316 |
|
| 2009 |
Jeon HJ, Kong DS, Park KB, Lee JI, Park K, Kim JH, Kim ST, Lim DH, Kim WS, Nam D. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: Single-center experience Clinical Neurology and Neurosurgery. 111: 679-682. PMID 19640635 DOI: 10.1016/J.Clineuro.2009.06.013 |
0.33 |
|
| 2009 |
Joo KM, Nam DH. Prospective identification of cancer stem cells with the surface antigen CD133 Methods in Molecular Biology (Clifton, N.J.). 568: 57-71. PMID 19582421 DOI: 10.1007/978-1-59745-280-9_5 |
0.337 |
|
| 2009 |
Kong DS, Nam DH, Lee JI, Park K, Kim JH, Shin HJ. Intracranial growing teratoma syndrome mimicking tumor relapse: a diagnostic dilemma. Journal of Neurosurgery. Pediatrics. 3: 392-6. PMID 19409018 DOI: 10.3171/2009.1.Peds0857 |
0.385 |
|
| 2009 |
Joo KM, Park IH, Shin JY, Jin J, Kang BG, Kim MH, Lee SJ, Jo M, Kim SU, Nam D. Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases. Molecular Therapy. 17: 570-575. PMID 19127251 DOI: 10.1038/Mt.2008.290 |
0.384 |
|
| 2009 |
Kong DS, Song SY, Kim DH, Joo KM, Yoo JS, Koh JS, Dong SM, Suh YL, Lee JI, Park K, Kim JH, Nam DH. Prognostic significance of c-Met expression in glioblastomas. Cancer. 115: 140-8. PMID 18973197 DOI: 10.1002/Cncr.23972 |
0.348 |
|
| 2008 |
Jeon HM, Jin X, Lee JS, Oh SY, Sohn YW, Park HJ, Joo KM, Park WY, Nam DH, DePinho RA, Chin L, Kim H. Inhibitor of differentiation 4 drives brain tumor-initiating cell genesis through cyclin E and notch signaling. Genes & Development. 22: 2028-33. PMID 18676808 DOI: 10.1101/Gad.1668708 |
0.354 |
|
| 2008 |
Kong DS, Lee JI, Park K, Kim JH, Lim DH, Nam DH. Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas. Cancer. 112: 2046-51. PMID 18338759 DOI: 10.1002/Cncr.23402 |
0.343 |
|
| 2008 |
Kong D, Kim MH, Park W, Suh Y, Lee J, Park K, Kim JH, Nam D. The progression of gliomas is associated with cancer stem cell phenotype. Oncology Reports. 19: 639-643. DOI: 10.3892/Or.19.3.639 |
0.404 |
|
| 2008 |
Joo KM, Park K, Kong D, Song SY, Kim MH, Lee GS, Kim MS, Nam D. Oral paclitaxel chemotherapy for brain tumors: ideal combination treatment of paclitaxel and P-glycoprotein inhibitor. Oncology Reports. 19: 17-23. DOI: 10.3892/Or.19.1.17 |
0.372 |
|
| 2008 |
Kong D, Kim M, Jeon J, Kim S, Kim MS, Joo KM, Park K, Nam D. Antitumor activity of ZD6474 in a metastatic orthotopic brain tumor model. Molecular Medicine Reports. 1: 343-346. DOI: 10.3892/Mmr.1.3.343 |
0.393 |
|
| 2007 |
Kong DS, Lee JI, Lim DH, Kim KW, Shin HJ, Nam DH, Park K, Kim JH. The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution. Cancer. 110: 854-60. PMID 17599761 DOI: 10.1002/Cncr.22860 |
0.308 |
|
| 2007 |
Ko KW, Nam DH, Kong DS, Lee JI, Park K, Kim JH. Relationship between malignant subtypes of meningioma and clinical outcome. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 14: 747-53. PMID 17499508 DOI: 10.1016/J.Jocn.2006.05.005 |
0.38 |
|
| 2007 |
Kwon KY, Kong DS, Lee JI, Nam DH, Park K, Kim JH. Outcome of repeated radiosurgery for recurrent metastatic brain tumors. Clinical Neurology and Neurosurgery. 109: 132-7. PMID 16930821 DOI: 10.1016/J.Clineuro.2006.06.007 |
0.354 |
|
| 2006 |
Kim JT, Kim JS, Ko KW, Kong DS, Kang CM, Kim MH, Son MJ, Song HS, Shin HJ, Lee DS, Eoh W, Nam DH. Metronomic treatment of temozolomide inhibits tumor cell growth through reduction of angiogenesis and augmentation of apoptosis in orthotopic models of gliomas. Oncology Reports. 16: 33-9. PMID 16786120 |
0.305 |
|
| 2006 |
Son MJ, Kim JS, Kim MH, Song HS, Kim JT, Kim H, Shin T, Jeon HJ, Lee DS, Park SY, Kim YJ, Kim JH, Nam DH. Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model. International Journal of Oncology. 28: 53-9. PMID 16327979 |
0.308 |
|
| 2006 |
Kong D, Lee J, Kim WS, Son MJ, Lim DH, Kim ST, Park K, Kim JH, Eoh W, Nam D. A pilot study of metronomic temozolomide treatment in patients with recurrent temozolomide-refractory glioblastoma. Oncology Reports. 16: 1117-1121. DOI: 10.3892/Or.16.5.1117 |
0.356 |
|
| 2006 |
Kim JT, Kim J, Ko KAW, Kong D, Kang C, Kim MH, Son MJ, Song HS, Shin H, Lee D, Eoh W, Nam D. Metronomic treatment of temozolomide inhibits tumor cell growth through reduction of angiogenesis and augmentation of apoptosis in orthotopic models of gliomas. Oncology Reports. 16: 33-39. DOI: 10.3892/Or.16.1.33 |
0.418 |
|
| 2006 |
Lee J, Itasaka S, Kim JT, Nam D. Antiangiogenic agent, thalidomide increases the antitumor effect of single high dose irradiation (gamma knife radiosurgery) in the rat orthotopic glioma model. Oncology Reports. 15: 1163-1168. DOI: 10.3892/Or.15.5.1163 |
0.394 |
|
| 2006 |
Son MJ, Song HS, Kim MH, Kim JT, Kang C, Jeon JW, Park S, Kim Y, Groves MD, Park K, Kim J, Nam D. Synergistic effect and condition of pegylated interferon α with paclitaxel on glioblastoma International Journal of Oncology. 28: 1385-1392. DOI: 10.3892/Ijo.28.6.1385 |
0.357 |
|
| 2006 |
Son MJ, Kim J, Kim MH, Song HS, Kim JT, Kim H, Shin T, Jeon HJ, Lee D, Park S, Kim Y, Kim J, Nam D. Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model. International Journal of Oncology. 28: 53-59. DOI: 10.3892/Ijo.28.1.53 |
0.42 |
|
| 2005 |
Nam TK, Lee JI, Jung YJ, Im YS, An HY, Nam DH, Park K, Kim JH. Gamma knife surgery for brain metastases in patients harboring four or more lesions: survival and prognostic factors. Journal of Neurosurgery. 102: 147-50. PMID 15662799 DOI: 10.3171/Jns.2005.102.S_Supplement.0147 |
0.315 |
|
| 2004 |
Nam D, Park K, Suh YL, Kim J. Expression of VEGF and brain specific angiogenesis inhibitor-1 in glioblastoma: prognostic significance. Oncology Reports. 11: 863-869. DOI: 10.3892/Or.11.4.863 |
0.393 |
|
| 2002 |
Nam DH, Song SY, Park K, Kim MH, Suh YL, Lee JI, Kim JS, Hong SC, Shin HJ, Park K, Eoh W, Kim JH. Clinical significance of molecular genetic changes in sporadic invasive pituitary adenomas. Experimental & Molecular Medicine. 33: 111-6. PMID 11642545 DOI: 10.1038/Emm.2001.20 |
0.321 |
|
| 1999 |
Nam DH, Cho BK, Shin HJ, Ahn HS, Kim IH, Wang KC. Treatment of intracranial nongerminomatous malignant germ cell tumor in children: the role of each treatment modality. Child's Nervous System : Chns : Official Journal of the International Society For Pediatric Neurosurgery. 15: 185-91. PMID 10361969 DOI: 10.1007/S003810050366 |
0.417 |
|
| 1992 |
Joo KM, Song SY, Park K, Kim MH, Jin J, Kang BG, Jang MJ, Lee GS, Kim MS, Nam D. Response of brain specific microenvironment to P-glycoprotein inhibitor: an important factor determining therapeutic effect of P-glycoprotein inhibitor on brain metastatic tumors. International Journal of Oncology. 33: 705-712. DOI: 10.3892/Ijo_00000056 |
0.378 |
|
| Show low-probability matches. |